Literature DB >> 3023106

A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats.

A G Ramage.   

Abstract

Preganglionic sympathetic nerve activity, blood pressure, heart rate and femoral arterial conductance were recorded in anaesthetised, paralysed cats. Urapidil, doxazosin and alfuzosin were infused i.v. for 1 h into different animals at the rate of 2 mg kg-1 h-1. All three drugs caused a fall in thoracic preganglionic sympathetic nerve activity along with blood pressure. Although urapidil had a greater hypotensive action than doxazosin and alfuzosin its sympathoinhibitory action was delayed and weaker. Since all three drugs are alpha 1-adrenoceptor antagonists it appears that antagonism at this receptor type may cause central sympathoinhibition as well as a decrease in total peripheral resistance. However, the different effects of urapidil suggest that its action on central sympathetic tone and therefore its hypotensive action cannot be due entirely to its ability to block alpha 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023106     DOI: 10.1016/0014-2999(86)90440-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Urapidil versus clonidine. Acute haemodynamic effects during control of intraoperative hypertensive episodes.

Authors:  W Hess
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  The role of alpha(1)-adrenoceptors and 5-HT(1A) receptors in the control of the micturition reflex in male anaesthetized rats.

Authors:  R K Conley; T J Williams; A P Ford; A G Ramage
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Evidence that different regional sympathetic outflows vary in their sensitivity to the sympathoinhibitory actions of putative 5-HT1A and alpha 2-adrenoceptor agonists in anaesthetized cats.

Authors:  A G Ramage; S J Wilkinson
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

Review 4.  Human pharmacology of urapidil.

Authors:  A M Shepherd
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors.

Authors:  A G Ramage
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 6.  Clinical pharmacokinetics of urapidil.

Authors:  R Kirsten; K Nelson; V W Steinijans; K Zech; R Haerlin
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

7.  Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.

Authors:  I K Anderson; G R Martin; A G Ramage
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

8.  Differential effects of centrally-active antihypertensives on 5-HT1A receptors in rat dorso-lateral septum, rat hippocampus and guinea-pig hippocampus.

Authors:  D J Leishman; P H Boeijinga; M Galvan
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

Review 9.  Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H D Langtry; G J Mammen; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

Review 10.  Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.

Authors:  R A Young; R N Brogden
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.